| Glycopyrrolate 1 MG [Robinul] |
| Glycopyrrolate 1 MG / Phenobarbital 15 MG Oral Tablet |
| GLYCOPYRROLATE 1 MG Oral (systemic) tablet |
| Glycopyrrolate 1 MG Oral Tablet |
| GLYCOPYRROLATE 1 mg ORAL TABLET [Glycopyrrolate] |
| Glycopyrrolate 1 MG Oral Tablet [Robinul] |
| GLYCOPYRROLATE 1 MILLIGRAM In 1 TABLET ORAL TABLET |
| Glycopyrrolate 1 MILLIGRAM In 1 TABLET ORAL TABLET [Glycopyrrolate] |
| Glycopyrrolate 1 MILLIGRAM In 1 TABLET ORAL TABLET [Robinul] |
| GLYCOPYRROLATE 100 %WW |
| GLYCOPYRROLATE 100% POWDER (GM) |
| GLYCOPYRROLATE 1MG ORAL TABLET |
| GLYCOPYRROLATE 1MG TAB |
| GLYCOPYRROLATE 1MG TAB [VA Product] |
| GLYCOPYRROLATE 1MG TABLET |
| Glycopyrrolate 2 MG |
| Glycopyrrolate 2 MG [Robinul] |
| Glycopyrrolate 2 MG / Phenobarbital 15 MG Oral Tablet |
| GLYCOPYRROLATE 2 MG Oral (systemic) tablet |
| Glycopyrrolate 2 MG Oral Tablet |
| GLYCOPYRROLATE 2 mg ORAL TABLET [Glycopyrrolate] |
| Glycopyrrolate 2 MG Oral Tablet [Robinul] |
| Glycopyrrolate 2 MG/ML |
| Glycopyrrolate 2 MG/ML Injectable Solution |
| GLYCOPYRROLATE 2 MILLIGRAM In 1 TABLET ORAL TABLET |
| Glycopyrrolate 2 MILLIGRAM In 1 TABLET ORAL TABLET [Glycopyrrolate] |
| Glycopyrrolate 2 MILLIGRAM In 1 TABLET ORAL TABLET [Robinul Forte] |
| Glycopyrrolate 2 MILLIGRAM In 1 TABLET ORAL TABLET [Robinul] |
| GLYCOPYRROLATE 2MG ORAL TABLET |
| GLYCOPYRROLATE 2MG TAB |
| GLYCOPYRROLATE 2MG TAB [VA Product] |
| GLYCOPYRROLATE 2MG TABLET |
| Glycopyrrolate 500 MG/ML |
| Glycopyrrolate 500 MG/ML / Neostigmine 2.5 MG/ML [Robinul-Neostigmine] |
| Glycopyrrolate 500 MG/ML / Neostigmine 2.5 MG/ML Injectable Solution |
| Glycopyrrolate 500 MG/ML / Neostigmine 2.5 MG/ML Injectable Solution [Robinul-Neostigmine] |
| Glycopyrrolate comp con |
| Glycopyrrolate comp unit |
| Glycopyrrolate Inj 0.4 MG/ML |
| Glycopyrrolate Inj 2 MG/ML |
| Glycopyrrolate Injectable Solution |
| Glycopyrrolate Injectable Solution [Robinul] |
| GLYCOPYRROLATE MISC. CRYSTALS |
| Glycopyrrolate Oral Tablet |
| Glycopyrrolate Oral Tablet [Robinul] |
| GLYCOPYRROLATE POWDER (GM) |
| Glycopyrrolate, 0.2 mg/ml injectable solution |
| Glycopyrrolate, 1 mg oral tablet |
| Glycopyrrolate, 2 mg oral tablet |
| GLYCOPYRROLATE, INHALATION SOLUTION ADMINISTERED THROUGH DME, CONCENTRATED FORM, PER MILLIGRAM |
| GLYCOPYRROLATE, INHALATION SOLUTION, COMPOUNDED PRODUCT, ADMINISTERED THROUGH DME, CONCENTRATED FORM, PER MILLIGRAM |
| GLYCOPYRROLATE, INHALATION SOLUTION, COMPOUNDED PRODUCT, ADMINISTERED THROUGH DME, UNIT DOSE FORM, PER MILLIGRAM |
| [email protected]/[email protected]@VIAL (SDV,MDV OR ADDITIVE) (ML) |
| [email protected]@[email protected] |
| [email protected]@[email protected] |
| GLYCOPYRROLATE/PHENOBARBITAL @ 1-15MG @ TABLET |
| GLYCOPYRROLATE/PHENOBARBITAL @ 2-15MG @ TABLET |
| GLYCOPYRROLATE/PHENOBARBITAL 1-15MG TABLET |
| GLYCOPYRROLATE/PHENOBARBITAL 2-15MG TABLET |
| Glycopyrronium Bromide |
| Glycopyrronium bromide 200micrograms/1mL injection (product) |
| Glycopyrronium bromide 600micrograms/3mL injection (product) |
| Glycoren |
| glycosaminoglucuronates |
| glycosaminoglycan |
| Glycosaminoglycan alpha-L-iduronohydrolase |
| glycosaminoglycan alpha-L-iduronohydrolase activity |
| glycosaminoglycan anabolism |
| glycosaminoglycan binding |
| glycosaminoglycan biosynthesis |
| glycosaminoglycan biosynthetic process |
| glycosaminoglycan breakdown |
| glycosaminoglycan catabolic process |
| glycosaminoglycan catabolism |
| glycosaminoglycan degradation |
| Glycosaminoglycan Degradation Pathway |
| glycosaminoglycan formation |
| glycosaminoglycan galactosyltransferase activity |
| glycosaminoglycan galactosyltransferase II, C elegans |
| glycosaminoglycan glucuronyltransferase I |
| glycosaminoglycan metabolic process |
| glycosaminoglycan metabolism |
| Glycosaminoglycan Metabolism Alteration |
| Glycosaminoglycan Metabolism Alteration [PE] |
| Glycosaminoglycan Metabolism Decrease |
| Glycosaminoglycan Metabolism Decrease [PE] |
| Glycosaminoglycan Metabolism Increase |
| Glycosaminoglycan Metabolism Increase [PE] |
| glycosaminoglycan polysulfate |
| glycosaminoglycan polysulfuric acid ester |
| glycosaminoglycan polysulphate |
| glycosaminoglycan receptor |
| glycosaminoglycan sulfotransferase |
| glycosaminoglycan synthesis |
| glycosaminoglycan-binding protein, Streptococcus pyogenes |
| glycosaminoglycan-peptide complex DAK 16 |
| glycosaminoglycan-stimulating factor |
| Glycosaminoglycans |
| Glycosaminoglycans [Chemical/Ingredient] |
| Glycosaminoglycans [Mass/volume] in Urine |
| Glycosaminoglycans [Presence] in Urine |
| Glycosaminoglycans | urine |
| Glycosaminoglycans nevus |
| Glycosaminoglycans pattern |
| Glycosaminoglycans pattern [interpretation] in Urine |
| Glycosaminoglycans pattern [interpretation] in Urine Narrative |
| Glycosaminoglycans pattern | urine |
| Glycosaminoglycans pattern:Imp:Pt:Urine:Nar |
| Glycosaminoglycans pattern:Imp:Pt:Urine:Nom |
| Glycosaminoglycans pattern:Impression/interpretation of study:Point in time:Urine:Narrative |
| Glycosaminoglycans pattern:Impression/interpretation of study:Point in time:Urine:Nominal |
| GLYCOSAMINOGLYCANS,MIXED @ @ CREAM (GRAMS) |
| GLYCOSAMINOGLYCANS,MIXED CREAM (GRAMS) |
| GLYCOSAMINOGLYCANS,MIXED/CL-XYLENOL/PROPYLPARABEN/PORCINE SK @ @ CREAM (GRAMS) |
| GLYCOSAMINOGLYCANS,MIXED/CL-XYLENOL/PROPYLPARABEN/PORCINE SK CREAM (GRAMS) |
| GLYCOSAMINOGLYCANS,MIXED/HUMECTANT COMPLEX @ @ CREAM (GRAMS) |
| GLYCOSAMINOGLYCANS,MIXED/HUMECTANT COMPLEX CREAM (GRAMS) |
| Glycosaminoglycans:ACnc:Pt:Urine:Ord |
| Glycosaminoglycans:Arbitrary Concentration:Point in time:Urine:Ordinal |
| Glycosaminoglycans:Mass Concentration:Point in time:Urine:Quantitative |
| Glycosaminoglycans:MCnc:Pt:Urine:Qn |
| Glycosaminoglycans/Creatinine |
| Glycosaminoglycans/Creatinine [Mass ratio] in 24 hour Urine |
| Glycosaminoglycans/Creatinine [Mass ratio] in Urine |
| Glycosaminoglycans/Creatinine [Molar ratio] in Urine |
| Glycosaminoglycans/Creatinine [Ratio] in Urine |
| Glycosaminoglycans/Creatinine:Mass Concentration Ratio:24 hours:Urine:Quantitative |
| Glycosaminoglycans/Creatinine:Mass Concentration Ratio:Point in time:Urine:Quantitative |
| Glycosaminoglycans/Creatinine:MCrto:24H:Urine:Qn |
| Glycosaminoglycans/Creatinine:MCrto:Pt:Urine:Qn |
| Glycosaminoglycans/Creatinine:Ratio:Pt:Urine:Qn |
| Glycosaminoglycans/Creatinine:Relative Density:Point in time:Urine:Quantitative |
| Glycosaminoglycans/Creatinine:ScRto:Pt:Urine:Qn |
| Glycosaminoglycans/Creatinine:Substance Concentration Ratio:Point in time:Urine:Quantitative |
| glycosaminoglycuronans |
| glycosidase |
| glycosidase activity |
| Glycosidase, Polynucleotide Adenosine |
| Glycosidase, Ura-DNA |
| Glycosidase, Uracil-DNA |
| Glycosidases |
| Glycoside |
| glycoside anabolism |
| glycoside biosynthesis |
| glycoside biosynthetic process |
| glycoside breakdown |
| glycoside catabolic process |
| glycoside catabolism |
| Glycoside Compound |
| glycoside degradation |
| glycoside formation |
| glycoside H2 |
| Glycoside Hydrolases |
| Glycoside Hydrolases [Chemical/Ingredient] |
| Glycoside Hydrolases, Nitrogen linked |
| Glycoside Hydrolases, Nitrogen-linked |
| glycoside metabolic process |
| glycoside metabolism |
| glycoside synthesis |
| Glycoside Transferases |
| glycoside-pentoside-hexuronide:cation symporter activity |
| Glycosides |
| Glycosides [Chemical/Ingredient] |
| Glycosides, Cardiac |
| Glycosides, Digitalis |
| glycosine |
| glycosinolate anabolism |
| glycosinolate biosynthesis |
| glycosinolate biosynthetic process |
| glycosinolate breakdown |
| glycosinolate catabolic process |
| glycosinolate catabolism |
| glycosinolate degradation |
| glycosinolate formation |
| glycosinolate metabolic process |
| glycosinolate metabolism |
| glycosinolate synthesis |
| Glycosmi |
| glycosminine |
| Glycosmis |
| Glycosmis chlorosperma |
| Glycosmis crassifolia |
| Glycosmis dinhensis |
| Glycosmis mauritiana |
| Glycosmis ovoidea |
| Glycosmis parva |
| Glycosmis parviflora |
| Glycosmis pentaphylla |
| Glycosmis pseudoracemosa |
| Glycosmis sapindoides |
| Glycosmis singuliflora |
| Glycosmis sp. RJB GH06-111 |
| Glycosmis trichanthera |
| Glycosmis trifoliata |
| Glycosome |
| glycosome lumen |
| glycosome membrane |
| Glycosomes |
| glycosparvarine |
| glycosphingolipid |
| Glycosphingolipid (GSL) |
| glycosphingolipid amidohydrolase activity |
| glycosphingolipid anabolism |
| glycosphingolipid beta 3-GlcNAcTase |
| glycosphingolipid beta 6-GlcNacTase |
| glycosphingolipid beta-galactosidase |
| glycosphingolipid beta1-3-N-acetylglucosaminyltransferase |
| glycosphingolipid beta1-6-N-acetylglucosaminyltransferase |
| glycosphingolipid binding |
| glycosphingolipid biosynthesis |
| glycosphingolipid biosynthetic process |
| glycosphingolipid breakdown |
| glycosphingolipid catabolic process |
| glycosphingolipid catabolism |
| glycosphingolipid ceramide deacylase |
| glycosphingolipid ceramide deacylase activity |
| glycosphingolipid CNS |
| glycosphingolipid COS |
| glycosphingolipid deacylase |
| glycosphingolipid deacylase activity |
| glycosphingolipid degradation |
| Glycosphingolipid deposition in all areas of the body |
| glycosphingolipid formation |
| glycosphingolipid GalGb3 |
| glycosphingolipid GSL-1 |
| glycosphingolipid GSL-3 |
| glycosphingolipid metabolic process |
| glycosphingolipid metabolism |
| glycosphingolipid sulfotransferase |
| glycosphingolipid sulfotransferase activity |
| glycosphingolipid synthesis |
| Glycosphingolipid Synthesis Alteration |
| Glycosphingolipid Synthesis Alteration [PE] |
| Glycosphingolipid Synthesis Decrease |
| Glycosphingolipid Synthesis Decrease [PE] |
| Glycosphingolipid Synthesis Increase |
| Glycosphingolipid Synthesis Increase [PE] |
| glycosphingolipidoses |
| Glycosphingolipids |
| Glycosphingolipids [Chemical/Ingredient] |
| Glycosphingolipids, Acidic |
| Glycosphingolipids, Neutral |
| glycosulfatase |
| glycosulfatase activity |
| glycosulfopeptide GSP-6 |
| glycosulphatase |
| glycosulphatase activity |
| Glycosuria |
| Glycosuria (less common) |
| Glycosuria [Disease/Finding] |
| glycosuria 1, renal |
| GLYCOSURIA FALSE POSITIVE |
| GLYCOSURIA FALSE POSITIVE TEST |
| GLYCOSURIA RENAL |
| Glycosuria, Renal |
| Glycosuria, Renal [Disease/Finding] |
| Glycosyl Ceramidase |
| glycosyl ceramide glycosylhydrolase activity |
| GLYCOSYL HYDROLASES N |
| glycosyl inositol phospholipid anchor-hydrolyzing enzyme activity |
| Glycosyl Phosphatidylinositol |
| Glycosyl Phosphatidylinositol Membrane Protein Anchors |
| glycosyl-albumin |
| glycosyl-N-acetyl-sphingosine 1,1-beta-D-glucanohydrolase activity |
| glycosyl-N-acylsphingosine glycohydrolase activity |
| glycosyl-phosphatidyl-inositol-MAM protein, human |
| Glycosyl-Phosphatidylinositol |
| Glycosyl-Phosphatidylinositol Membrane Protein Anchors |
| glycosyl-phosphatidylinositol-anchored renal dipeptidase activity |
| glycosyl-phosphatiylinositol-anchored dipeptidase |
| glycosylase |
| Glycosylase, DNA |
| Glycosylase, Methylpurine DNA |
| Glycosylase, RNA |
| Glycosylase, Thymine DNA |
| Glycosylase, Thymine Glycol |
| Glycosylase, Ung DNA |
| Glycosylase, Ura-DNA |
| Glycosylase, Uracil DNA |
| Glycosylase, Uracil-DNA |
| Glycosylases, DNA |
| Glycosylasparaginase |
| glycosylasparaginase activity |
| GLYCOSYLASPARAGINASE DEFICIENCY |
| Glycosylated A1a-1 Hemoglobin |
| Glycosylated A1b Hemoglobin |
| glycosylated Aalpha chain fibrinogen |
| glycosylated AFP protein, human |
| glycosylated alpha-amylase |
| glycosylated apo-B |
| glycosylated apo-B (LDL) |
| glycosylated blood proteins |
| glycosylated collagen |
| glycosylated crystallin |
| glycosylated ferritin |
| glycosylated ferritins |
| glycosylated fetal hemoglobin |
| glycosylated fibrinogen |
| glycosylated fibronectin |
| glycosylated gamma interferon |
| glycosylated growth hormone |
| glycosylated Hb E |
| glycosylated HCG |
| glycosylated hemoglobin |
| Glycosylated hemoglobin A |
| Glycosylated Hemoglobin Analyzers |
| Glycosylated Hemoglobin Determination Reagents |
| glycosylated hemoglobin E |
| GLYCOSYLATED HEMOGLOBIN ELEVATED |
| Glycosylated Hemoglobin Measurement |
| Glycosylated Hemoglobins Test |
| glycosylated human chorionic gonadotropin |
| glycosylated human T cell growth factor |
| glycosylated hydroxylysine |
| glycosylated IgA |
| glycosylated IgG |
| glycosylated IgM |
| glycosylated IL-2 |
| glycosylated insulin |
| glycosylated interferon, gamma |
| glycosylated isoferritin |
| Glycosylated Keratin |
| glycosylated lipoproteins, HDL |
| glycosylated lipoproteins, LDL |
| glycosylated lipoproteins, VLDL |
| glycosylated lysine |
| Glycosylated MUC-1 |
| glycosylated peptide 31D |
| Glycosylated Phosphatidylinositols |
| glycosylated pituitary growth hormone |
| glycosylated pro-Con A |
| glycosylated prolactin |
| Glycosylated Protein Determination Reagents |
| Glycosylated Recombinant G-CSF |
| Glycosylated Recombinant Granulocyte Colony-Stimulating Factor |
| Glycosylated Recombinant Human G-CSF AVI-014 |
| glycosylated recombinant human INF-beta |
| Glycosylated Recombinant Human Interleukin-7 |
| glycosylated renin |
| Glycosylated rhIL-7 |
| glycosylated serum albumin |
| glycosylated serum protein |
| glycosylated silk protein, 160-kDa, Chironomus thummi |
| glycosylated somatotropin |
| glycosylated triiodothyronine |
| glycosylation |
| glycosylation dependent cell adhesion molecule 1 (pseudogene) |
| Glycosylation End Products, Advanced |
| Glycosylation End Products, Advanced [Chemical/Ingredient] |
| glycosylation end products, advanced-bovine serum albumin |
| glycosylation end products, human serum albumin |
| glycosylation inhibiting factor |
| Glycosylation of N-linked Oligosaccarides Pathway |
| Glycosylation Site Binding Protein |
| Glycosylation Site-Binding Protein |
| glycosylation-dependent cell adhesion molecule 1 |
| glycosylation-enhancing factor |
| Glycosylation-Inhibiting Factor |
| Glycosylation-Inhibiting Factor Gene |
| Glycosylation, Protein |
| Glycosylations |
| Glycosylations, Protein |
| Glycosylceramidase |
| Glycosylceramidase [Chemical/Ingredient] |
| glycosylceramidase activity |
| glycosylceramide anabolism |
| glycosylceramide biosynthesis |
| glycosylceramide biosynthetic process |
| glycosylceramide breakdown |
| glycosylceramide catabolic process |
| glycosylceramide catabolism |
| glycosylceramide degradation |
| glycosylceramide formation |
| glycosylceramide metabolic process |
| glycosylceramide metabolism |
| glycosylceramide synthesis |
| glycosylceramide synthetase |
| Glycosylphosphatidylinositol |
| glycosylphosphatidylinositol anchor attachment 1 pseudogene 1 |
| GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR ATTACHMENT PROTEIN 1 |
| glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast) |
| glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 |
| glycosylphosphatidylinositol anchored molecule like protein |
| Glycosylphosphatidylinositol Anchors |
| glycosylphosphatidylinositol binding |
| glycosylphosphatidylinositol biosynthesis |
| glycosylphosphatidylinositol biosynthetic process |
| GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY |
| GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY, -270C-G |
| Glycosylphosphatidylinositol Diacylglycerol Lyase |
| Glycosylphosphatidylinositol Diacylglycerol-Lyase |
| glycosylphosphatidylinositol diacylglycerol-lyase activity |
| glycosylphosphatidylinositol inositol deacylase, Trypanosoma brucei |
| Glycosylphosphatidylinositol Linkage |
| glycosylphosphatidylinositol MAM protein, human |
| glycosylphosphatidylinositol mannosyltransferase I |
| glycosylphosphatidylinositol metabolic process |
| glycosylphosphatidylinositol metabolism |
| glycosylphosphatidylinositol phospholipase D activity |
| glycosylphosphatidylinositol protein 2, S cerevisiae |
| glycosylphosphatidylinositol protein 8, S cerevisiae |
| glycosylphosphatidylinositol protein 8, S pombe |
| glycosylphosphatidylinositol protein C, human |
| glycosylphosphatidylinositol protein O, human |
| glycosylphosphatidylinositol protein O, mouse |
| Glycosylphosphatidylinositol Specific Phospholipase C |
| glycosylphosphatidylinositol specific phospholipase D1 |
| GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED HIGH DENSITY LIPOPROTEIN-BINDING PROTEIN 1 |
| glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1, human |
| glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1, mouse |
| GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED MOLECULE-LIKE PROTEIN |
| Glycosylphosphatidylinositol-anchored molecule-like protein, human |
| glycosylphosphatidylinositol-linked glycoprotein-2 |
| GLYCOSYLPHOSPHATIDYLINOSITOL-MAM |
| glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex |
| glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex location |
| glycosylphosphatidylinositol-phospholipase C activity |
| Glycosylphosphatidylinositol-Specific Phospholipase C |
| glycosylphosphatidylinositol-specific phospholipase C activity |
| glycosylphosphatidylinositol-specific phospholipase D |
| Glycosylphosphatidylinositol(GPI)-anchor Biosynthesis |
| Glycosylphosphatidylinositol(GPI)-anchor Biosynthesis Pathway |
| Glycosylphosphatidylinositols |
| Glycosylphosphatidylinositols [Chemical/Ingredient] |
| glycosylthiomethyl chloride |
| glycosyltransferase |
| glycosyltransferase 1 domain containing 1 |
| glycosyltransferase 25 domain containing 1 |
| glycosyltransferase 25 domain containing 2 |
| glycosyltransferase 25 domain containing 3 |
| glycosyltransferase 6 domain containing 1 |
| glycosyltransferase 8 domain containing 1 |
| glycosyltransferase 8 domain containing 2 |
| glycosyltransferase 8 domain containing 3 |
| glycosyltransferase 8 domain containing 4 |
| glycosyltransferase activity |
| Glycosyltransferase Gene |
| GLYCOSYLTRANSFERASE-LIKE 1B |
| glycosyltransferase-like 1B protein, human |
| glycosyltransferase-like 1B protein, mouse |
| glycosyltransferase-like domain containing 1 |
| glycosyltransferase-like domain containing 1 protein, human |
| GLYCOSYLTRANSFERASE-LIKE DOMAIN-CONTAINING 1 |
| glycosyltransferase-like protein LARGE1, human |
| Glycosyltransferase, Branching |
| Glycosyltransferase, Peptidoglycan |
| glycosyltransferase, Sulfolobus |
| Glycosyltransferases |
| Glycosyltransferases [Chemical/Ingredient] |
| glycosyltrehalose-producing enzyme |
| glycosyn 2 |
| glycosyn-2 |
| glycothiohexide alpha |
| glycothiohexide alpha aglycone |
| glycotop |
| glycotriosyl asperagine |
| glycotriosyl glutamine |
| Glycotuss-DM |
| Glycotuss-DM, 10 mg-100 mg oral tablet |
| glycoursodeoxycholic acid |
| glycovir |
| glycoyessotoxin |
| glycoyessotoxin A |
| glycoyl-CoA |
| glycoyl-coenzyme A |
| glycozoline |
| glycozolinol |
| Glycron |
| Glycron 1.5 MG Oral Tablet |
| Glycron 3 MG Oral Tablet |
| Glycron 4.5 MG Oral Tablet |
| Glycron 6 MG Oral Tablet |
| Glycron, micronized 1.5 mg oral tablet |
| Glycron, micronized 3 mg oral tablet |
| Glycron, micronized 4.5 mg oral tablet |
| Glycron, micronized 6 mg oral tablet |
| GLYCTK |
| GLYCTK gene |
| GLYCTK1 |
| GLYCTK2 |
| glycuronidase activity |
| Glycuronoglycosphingolipid |
| glycvidon |
| glycyclamide |
| Glycycometus geniculatus |
| glycycoumarin |
| Glycydendron |
| Glycydendron amazonicum |
| glycyl alanine |
| glycyl aminopeptidase |
| glycyl compound |
| glycyl endopeptidase |
| Glycyl Glycine |
| glycyl glycyl histidine |
| glycyl peptidase |
| Glycyl T RNA Synthetase |
| glycyl translase activity |
| Glycyl tRNA Synthetase |
| glycyl- arginyl-glycyl-aspartyl-seryl-prolyl-lysine |
| glycyl-(ethyl)lysyl-prolyl-arginine |
  121 122 123 124 125   |
